Latest Ratios: P/E Ratio -5.5x · EV/EBITDA N/A · ROE -11.8%. (2019–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $88M | — | $493M | $387M | $681M | $4.5B | — | — |
| Enterprise Value | $87M | — | $492M | $387M | $676M | $4.5B | — | — |
| P/E Ratio → | -5.55 | — | — | — | — | — | — | — |
| P/S Ratio | 1.49 | — | 8.28 | 5.09 | 20.40 | 506.48 | — | — |
| P/B Ratio | 19.61 | 0.09 | 109.26 | 60.48 | 12.08 | 59.11 | — | — |
| P/FCF | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | — | 8.26 | 5.08 | 20.25 | 502.44 | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 43.3% | 43.3% | 21.0% | 23.3% | 39.7% | 27.0% | 67.0% | — |
| Operating Margin | -30.7% | -30.7% | -26.3% | -66.2% | -141.4% | -211.6% | -13475.5% | — |
| Net Profit Margin | -30.5% | -30.5% | -26.7% | -75.0% | -156.9% | -236.6% | -13367.9% | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| ROE | -11.8% | -11.8% | -291.5% | -181.6% | -78.6% | -45.6% | -189.6% | — |
| ROA | -5.7% | -5.7% | -63.8% | -109.0% | -63.0% | -40.5% | -137.4% | -242.5% |
| ROIC | -5.5% | -5.5% | -257.3% | -132.6% | -77.1% | -67.8% | -1700.5% | — |
| ROCE | -6.9% | -6.9% | -212.3% | -142.1% | -66.1% | -39.6% | -182.5% | — |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.76 | 0.76 | 1.09 | 0.57 | 0.07 | 0.02 | 0.04 | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | 0.69 | -0.25 | -0.11 | -0.09 | -0.47 | -0.92 | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — |
| Interest Coverage | -101.30 | -101.30 | -73.45 | -547.33 | — | -593.84 | -476.13 | -144.65 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.01 | 1.01 | 1.05 | 1.31 | 1.79 | 7.84 | 6.43 | 0.21 |
| Quick Ratio | 0.79 | 0.79 | 0.74 | 0.79 | 1.28 | 7.34 | 6.23 | 0.21 |
| Cash Ratio | 0.65 | 0.65 | 0.32 | 0.27 | 0.51 | 6.15 | 5.66 | 0.06 |
| Asset Turnover | — | 0.11 | 2.27 | 3.22 | 0.41 | 0.11 | 0.01 | — |
| Inventory Turnover | 4.33 | 4.33 | 8.15 | 6.86 | 2.30 | 2.16 | 0.06 | — |
| Days Sales Outstanding | — | 20.11 | 44.79 | 34.08 | 97.90 | 227.50 | 4214.72 | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | — | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | — | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $0 | $12M | $7M | $4M | $3M | $2M | $4M |
Imminent liquidity and insolvency
Based on reported figures, Flora Growth's P/S ratio of 1.49 and negative P/E multiple suggest that the market currently prices the company as a distressed asset rather than a growth-oriented CPG entity, reflecting deep skepticism regarding its ability to achieve sustainable profitability in the near term.
The absence of a meaningful forward P/E or EV/EBITDA multiple indicates that investors are struggling to anchor a valuation on traditional earnings metrics. This pricing suggests that the market is heavily discounting the company's future cash flows, likely due to the persistent revenue contraction and the high probability of further equity dilution.
As reported in recent financial statements, the company's gross margin volatility, which plummeted to -1.1% in 2025Q4, highlights a fundamental inability to maintain pricing power or control logistics costs, rendering traditional operating margin analysis largely ineffective for assessing the company's true underlying earning potential.
The erratic nature of these margins suggests that the business model is highly sensitive to external cost pressures and inventory write-downs. Investors should monitor whether the company can stabilize its gross margins before attempting to evaluate its long-term operating leverage, as current figures appear heavily distorted by non-recurring operational disruptions.
According to quarterly data, the company's cash conversion cycle has remained consistently elevated, with DIO figures often exceeding 200 days, which indicates significant challenges in managing inventory turnover and suggests that capital is being trapped in slow-moving products rather than generating efficient operational returns.
The inability to optimize the cash conversion cycle appears to be a primary driver of the company's persistent liquidity strain. This inefficiency forces a reliance on external financing, as the business fails to convert its inventory into cash at a pace sufficient to cover its ongoing corporate overhead.
Based on the latest quarterly filings, the company's debt-to-equity ratio has reached 0.76, signaling a concerning shift toward debt financing at a time when operational performance is deteriorating, which warrants further investigation into the company's ability to service these obligations without further diluting existing shareholders.
The interest coverage ratio, which has frequently turned negative, suggests that the company is not generating sufficient operating income to comfortably meet its debt service requirements. This leverage profile appears increasingly unsustainable, particularly given the company's limited cash reserves and the ongoing volatility in its core revenue streams.
The P/B ratio of 19.61 is frequently misapplied to Flora Growth, as it obscures the reality that the company's book value is heavily influenced by intangible assets and goodwill that have historically been subject to significant impairment, rather than representing tangible, productive capital.
Investors should instead focus on the company's cash runway and tangible asset base, as the P/B ratio provides a misleading sense of asset backing. Given the history of write-downs, the book value likely overstates the company's liquidation value, making it a poor metric for assessing the downside risk of this business model.
Includes 30+ ratios · 7 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying FLGC stock.
Flora Growth Corp.'s current P/E ratio is -5.5x. This places it at the 50th percentile of its historical range.
Flora Growth Corp.'s return on equity (ROE) is -11.8%. The historical average is -133.1%.
Based on historical data, Flora Growth Corp. is trading at a P/E of -5.5x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Flora Growth Corp. has 43.3% gross margin and -30.7% operating margin.